Kaye, Donald
May 2004
Clinical Infectious Diseases;5/15/2004, Vol. 38 Issue 10, piv
Academic Journal
The article reports that, the drug maker Bayer Corp. lost an appeal of the US government's proposed ban of a poultry antibiotic that regulators partly blame for a rise in drug-resistant germs that infect people. The company is contesting an Food and Drug Administration's proposal made in 2000 to outlaw Baytril, part of a family of potent antibiotics known as fluoroquinolones that doctors consider valuable for treating serious infections in people. Bayer plans to appeal the judge's decision to the FDA commissioner, who has the authority to make the final decision.


Related Articles

  • Antibiotic Use in Agriculture Made News This Week. Berg, Lora // National Hog Farmer Expert Blog;12/13/2013, p14 

    The article discusses the final guidance issued by the U.S. Food and Drug Administration (FDA) in December 2013 on two proposals aimed at dealing with increasing concerns about antimicrobial resistance in humans. It references the report at www.meatingplace.com and the article "Will FDA's...

  • [Commentary on] Dose Imprecision and Resistance: Free-Choice Medicated Feeds in Industrial Food Animal Production in the United States. Love, David C.; Davis, Meghan F.; Bassett, Anna; Gunther, Andrew; Nachman, Keeve E. // Environmental Health Perspectives;Mar2011, Vol. 119 Issue 3, p279 

    BACKGROUND: Industrial food animal production employs many of the same antibiotics or classes of antibiotics that are used in human medicine. These drugs can be administered to food animals in the form of free-choice medicated feeds (FCMF), where animals choose how much feed to consume. Routine...

  • The other SHOE.  // Meatingplace;Nov2014, Vol. 22 Issue 11, p10 

    The article focuses on the commitment of Tyson Foods to discontinue use of antibiotics at its chicken hatcheries. Topics discussed include global action plan to address antimicrobial resistance announced by the World Health Organization (WHO), role of antibiotics usage in agriculture on...

  • Wyeth's Tygacil Antibiotic Will Be Manufactured in Carolina Plant. Martinez, Mariaalba // Caribbean Business;6/23/2005, Vol. 33 Issue 24, p2 

    Reports on the U.S. Food and Drug Administration's approval of Wyeth's Tygacil antibiotic. Manufacture of the antibiotic in Carolina; Ability of the drug to overcome bacterial resistance found in communities or hospitals.

  • R&D Costs, Reimbursement Challenges in War Against Bugs.  // BioWorld Today;1/31/2013, Vol. 24 Issue 21, p1 

    The article reports on the actions being made by the U.S. Food and Drugs Administration (FDA) to create approval shortcuts for antimicrobial drugs. It says that a public hearing will be headed by FDA that would give drugmakers incentives to encourage them to develop antibiotics for the patients...

  • Set a Microbe to Kill a Microbe: Drug Resistance Renews Interest in Phage Therapy. Thacker, Paul D. // JAMA: Journal of the American Medical Association;12/24/2003, Vol. 290 Issue 24, p3183 

    Focuses on research into drug resistant microbes. Use of a microbe to kill a microbe; Actions of phages; How phage therapy predated antibiotics by decades; How phage therapy is still in a premature stage due to technology; How regulations by the U.S. Food & Drug Administration could prevent...

  • FDA's Role -- Antimicrobial Resistance.  // Biomedical Market Newsletter;3/7/2011, p584 

    The article presents a speech by Bernadette Dunham, Director of the Food and Drug Administration's (FDA's) Center for Veterinary Medicine (CVM), delivered before the U.S. Subcommittee on Livestock, Dairy and Poultry House Committee on Agriculture, in September 2008, in which he discussed FDA's...

  • Emerging Resistance, New Antimicrobial Agents . . . but No Tests! The Challenge of Antimicrobial Susceptibility Testing in the Current US Regulatory Landscape. Humphries, R. M.; Hindler, J. A. // Clinical Infectious Diseases;7/1/2016, Vol. 63 Issue 1, p83 

    Accurate and timely performance of antimicrobial susceptibility testing (AST) by the clinical laboratory is paramount to combating antimicrobial resistance. The ability of laboratories in the United States to effectively perform ASTs is challenged by several factors. Some, such as new resistance...

  • GAO chides federal agencies for lack of data on antimicrobial use, resistance. WHITCOMB, RACHAEL // DVM: The Newsmagazine of Veterinary Medicine;Nov2011, Vol. 42 Issue 11, p30 

    The article reports that according to a new report from the U.S. Government Accountability Office (GAO), the U.S. Food and Drug Administration (FDA) and other federal agencies responsible for monitoring antimicrobial use and resistance are not able to predict accurate trends. It says that the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics